Clinical Trials Logo
  1. Home
  2. Ovarian Epithelial Cancer
  3. NCT05937620

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer — Melisa-II  

Ovarian Epithelial Cancer Clinical Trial

Official title:
Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and Indocyanine Green (ICG) in Patients With Epithelial Ovarian Cancer in Early Stages: Pilot Study

Clinical Trial Summary

Study to evaluate the diagnostic precision of ICG and 99mTc nanocolloid albumin in sentinel lymph node detection in early ovarian epithelial cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05937620
Study type Interventional
Source Fundacion Clinic per a la Recerca Biomédica
Contact Laura Burunat, Graduate
Phone 932275400
Email burunat@recerca.clinic.cat
Status Not yet recruiting
Phase N/A
Start date November 2023
Completion date October 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT02096783 - Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer N/A
Active, not recruiting NCT01456065 - Safety of Active Immunotherapy in Subjects With Ovarian Cancer Phase 1
Recruiting NCT06404671 - Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer N/A
Recruiting NCT05001282 - A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRĪ±) Phase 1/Phase 2
Not yet recruiting NCT03220932 - Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer Phase 3
Completed NCT02039388 - Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma N/A
Completed NCT02107950 - Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma Phase 2
Completed NCT02107937 - Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma Phase 2
Completed NCT01806350 - Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors N/A
Recruiting NCT03349463 - Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. Phase 4
Completed NCT04823871 - Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing N/A
Completed NCT02518256 - Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity N/A
Active, not recruiting NCT03078400 - Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer Phase 1
Not yet recruiting NCT02435186 - p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer Phase 2
Completed NCT02489903 - RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) Phase 2
Recruiting NCT04029909 - A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Phase 1
Recruiting NCT05498597 - AMT-151 in Patients With Selected Advanced Solid Tumours Phase 1
Suspended NCT02742428 - Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer N/A
Active, not recruiting NCT02981901 - Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France
Completed NCT02062697 - Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes. N/A